68 In two clinical studies (study B2222 and an intergroup study S0033) the daily dose of Glivec was escalated to 800 mg in patients progressing at the lower daily doses of 400 mg or 600 mg.
Kahes kliinilises uuringus (uuring B2222 ja rühmadevaheline uuring S0033) suurendati Glivec’ i annust 800 mg- ni patsientidel, kellel haigus progresseerus annuste 400 mg ja 600 mg kasutamisel.